Trials / Completed
CompletedNCT01476930
Cupping and Serkangabin Versus Conventional Migraine Treatment
Cupping Therapy and SERKANGABIN Versus Conventional Treatment of Migraine Headache: a Randomized Controlled Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 391 (actual)
- Sponsor
- Birjand University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 15 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
Migraine is the most common recurrent headache. Current therapy of migraine headache consists of multiple drug groups for control of attack and prophylaxis against recurrent attacks. Emerging alternative medicine worldwide led investigators to evaluate the efficacy of cupping therapy plus SERKANGABIN syrup in treatment of migraine headache. Severity, duration and frequency of attacks of migraine headache evaluated in two groups during six months from presentation.
Detailed description
In a randomized controlled trial investigators randomly assigned 76 patients with migraine to cupping therapy plus SERKANGABIN or to receive conventional medical treatment. The use of CAM in migraine is a growing phenomenon. Migraine patients seek and explore both conventional and CAM approaches. Wet cupping is an ancient medical technique still used in several contemporary societies. It is being used in management of hypertension, diabetes mellitus, and headaches, renal and biliary stones and for maintaining health. Little experimental study has been devoted to test its efficacy to treat migraine headache. Investigators planned this study for evaluation of therapeutic efficacy of wet cupping and an Iranian traditional medicine preparation, SERKANGABIN in treatment of migraine headache compared with current medicine protocols. SERKANGABIN is a preparation of honey, vinegar and distilled mint water that in traditional Iranian medicine is believed to have therapeutic effects in many diseases (diabetes mellitus, hypertension, hyperlipidemia, osteoarthritis, chronic obstructive airway disease, interstitial lung disease, hepatitis, fatty liver, ischemic heart disease, migraine, cerebrovascular diseases)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | cupping and serkangabin syrup | wet cupping serkangabin syrup |
| DRUG | conventional migraine drug treatment | nortriptyline ,propranolol ,ergotamine , sumatriptan tablets |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-09-01
- Completion
- 2011-10-01
- First posted
- 2011-11-22
- Last updated
- 2014-11-24
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT01476930. Inclusion in this directory is not an endorsement.